跳至主要内容
临床试验/NCT00626977
NCT00626977已完成不适用

Labor Analgesia With Ropivacaine Added to Clonidine. A Randomized Clinical Trial

UPECLIN HC FM Botucatu Unesp1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2000年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
32
试验地点
1

研究概览

简要总结

The aim of the present study was to examine, for pain relief during labor, the efficacy of two pharmacological approaches - the 0.125% ropivacaine alone and the 0.0625% ropivacaine added to 75 ug clonidine, both by epidural administration. The effect of the drugs on mother and newborn was also determined.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Singleton healthy
  • Full-term pregnancy
  • American Society of Anesthesiologists physical status I or II

排除标准

  • Patients who had received opioids
  • History of hypersensitivity to local anesthetic or to clonidine
  • Fetus showed signs of possible intrauterine suffering
  • Fetus showed signs of possible neurological deficit

研究组 & 干预措施

R

R group:15 mL of 0.125% ropivacaine (18.75 mg)

干预措施: ropivacaine (Drug)

RC

RC group:0.0625% ropivacaine (9.375 mg) plus 75 ug clonidine

干预措施: ropivacaine and clonidine (Drug)

研究者

发起方
UPECLIN HC FM Botucatu Unesp
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yara Marcondes Machado Castiglia

MD PhD

UPECLIN HC FM Botucatu Unesp

研究点 (1)

Loading locations...

相似试验